Synteract acquires KinderPharm to be ‘one-stop shop’ for pediatric clinical trials 19-Nov-2018 By Melissa Fassbender Synteract’s clients will benefit from a single source model, says CEO, following the acquisition of KinderPharm, a PA-based CRO focused on all phases of pediatric drug development.